|
DYNLT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.171020E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.55639999999924E-05 |
| Normal-vs-Stage2 |
1.553890E-02 |
| Normal-vs-Stage3 |
1.201330E-03 |
| Normal-vs-Stage4 |
2.978700E-04 |
| Stage1-vs-Stage2 |
9.841800E-01 |
| Stage1-vs-Stage3 |
9.814400E-01 |
| Stage1-vs-Stage4 |
3.644600E-01 |
| Stage2-vs-Stage3 |
9.947000E-01 |
| Stage2-vs-Stage4 |
5.876600E-01 |
| Stage3-vs-Stage4 |
4.662200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.446700E-04 |
| Normal-vs-AfricanAmerican |
1.598480E-02 |
| Normal-vs-Asian |
2.241100E-03 |
| Caucasian-vs-AfricanAmerican |
8.818800E-01 |
| Caucasian-vs-Asian |
9.279000E-01 |
| AfricanAmerican-vs-Asian |
9.347800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.617560E-04 |
| Normal-vs-Female |
2.416500E-04 |
| Male-vs-Female |
3.469800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.412400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.26090000002388E-06 |
| Normal-vs-Age(61-80Yrs) |
1.262420E-03 |
| Normal-vs-Age(81-100Yrs) |
4.970800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.246000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.671400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.866400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.811600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.702440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.994200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.556200E-01 |
| Classical-VS-Follicular |
4.37549999999787E-05 |
| Classical-VS-Other |
1.575800E-01 |
| Classical-VS-Normal |
4.256200E-03 |
| Tall-VS-Follicular |
8.138900E-03 |
| Tall-VS-Other |
1.883820E-01 |
| Tall-VS-Normal |
1.439960E-01 |
| Follicular-VS-Other |
9.601800E-01 |
| Follicular-VS-Normal |
1.46510000020861E-07 |
| Other-VS-Normal |
1.338110E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15510000000085E-05 |
| Normal-vs-N1 |
3.001500E-04 |
| N0-vs-N1 |
8.841200E-01 |
|
|
